353 related articles for article (PubMed ID: 1845106)
1. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
3. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
4. [Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
Ryo R; Sugano W; Yoshida A; Adachi M; Yasunaga M; Yoneda N; Saigo K; Kondo S; Yamaguchi N; Nobusawa A
Gan No Rinsho; 1989 Oct; 35(12):1479-82. PubMed ID: 2810783
[TBL] [Abstract][Full Text] [Related]
5. Intravascular coagulation and fibrinolysis syndrome (ICF) in acute non-promyelocytic leukemia.
Kotschy M; Kotlarek-Haus S; Podolak-Dawidziak M; Nowicka J; Dzik T
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):65-73. PubMed ID: 6157626
[TBL] [Abstract][Full Text] [Related]
6. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
[TBL] [Abstract][Full Text] [Related]
8. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
9. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
Collatos C; Barton MH; Prasse KW; Moore JN
J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Okajima K; Koga S; Okabe H; Inoue M; Takatsuki K
Acta Haematol; 1989; 81(1):15-8. PubMed ID: 2494830
[TBL] [Abstract][Full Text] [Related]
11. Activation of the fibrinolytic system in patients with fulminant liver failure.
Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
[TBL] [Abstract][Full Text] [Related]
12. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
13. [Disseminated intravascular coagulation (D.I.C.) and fibrinolysis in patients with acute leukemia (author's transl)].
Bunjevacki G; Sultan Y; Izraël V
Nouv Rev Fr Hematol (1978); 1978; 20(4):575-84. PubMed ID: 752151
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
[TBL] [Abstract][Full Text] [Related]
16. [Blood coagulation disorders in leukemia].
Pabinger-Fasching I
Wien Med Wochenschr; 1991; 141(9-10):213-6. PubMed ID: 1949847
[TBL] [Abstract][Full Text] [Related]
17. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
18. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
Madoiwa S
Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
[No Abstract] [Full Text] [Related]
19. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
[No Abstract] [Full Text] [Related]
20. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
Astrup T; Jespersen J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
